Previous studies have demonstrated the AR acts as a licensing factor in DNA replication in androgen sensitive prostate cancer cells and that androgens induce double-strand DNA breaks within prostate cancer cell lines [18–21]. This evidence concerns the gene AR and prostate carcinoma.